Search

everythinglearnresearchcommunity

for

Search:↓

PRP treatment increases hair density and thickness in androgenetic alopecia by 79%.

Terbinafine is the most effective treatment for tinea capitis, a scalp infection often confused with other conditions.

A 15-year-old boy's severe scalp condition improved significantly with adalimumab and baricitinib treatment.

A baby was diagnosed with IFAP syndrome due to a new genetic mutation, showing severe skin and developmental issues.

Hair loss in children is often caused by scalp infections, immune disorders, hair pulling, stress, and requires careful treatment due to emotional effects.

Oral minoxidil can potentially increase hair growth in people suffering from Central Centrifugal Cicatricial Alopecia.

Accurate diagnosis of pseudolymphomatous folliculitis is crucial to avoid mistaking it for more serious conditions.

Pica disorder in central Iraq is mainly found in females and is linked to low iron levels; treatment with iron improves most patients.

The document concludes that correct diagnosis of alopecia types is crucial, scalp biopsies are important, and more research is needed.

PRP injections can increase hair density in people with androgenic alopecia.

A woman's long-term scalp issues were diagnosed as a rare skin disorder called cutaneous Langerhans cell histiocytosis.

Dermatological conditions are complex and treatments often have mixed results.

The document says that treating the root cause of hair follicle damage is crucial to prevent permanent hair loss, and treatment options vary.

The document concludes that various childhood hair and nail disorders exist, some may improve on their own, and advances in genetics and immunology could enhance treatment and counseling.

Doctors should diagnose hair loss by examining the patient and possibly doing tests, and then treat it based on the type, which may prevent permanent hair loss.

Taking a probiotic supplement twice a day improved hair growth, skin hydration, and metabolic health in adults at risk of metabolic syndrome.

CCCA is a scarring hair loss condition mainly in African descent women, possibly caused by genetics and hairstyling, treated with gentle hair care and medications.

The document concludes that stopping shaving or removing affected hair can alleviate Pseudofolliculitis barbae (PFB).

Probiotics help reduce hair loss and increase hair growth in people with androgenic alopecia.

Pregnancy can cause various skin changes and diseases, requiring careful treatment to protect the baby.

DCPA is a chronic skin condition affecting the legs, often misdiagnosed, and needs more research for better understanding and treatment.

Some treatments for folliculitis decalvans work well, with tetracyclines and a mix of rifampicin and clindamycin being most effective.

Human scalp hair follicles can produce hormones and have a system similar to a brain-body communication network.

Telogen Effluvium is a common, usually reversible hair loss condition, often improved by removing the trigger and possibly treated with various products, though their effectiveness is uncertain.

Caffeine improves hair growth, thickness, and reduces shedding.

The document concludes that treatments for cicatricial alopecia are not well-supported by evidence, but hair transplantation shows more predictable and satisfactory results.

Hormones like testosterone and estrogen significantly affect hair growth and structure.

The most common cause of hair loss in children is tinea capitis, followed by alopecia areata and telogen effluvium.

Androgenetic alopecia is a common hair loss condition influenced by various factors and linked to psychosocial and cardiovascular issues.

The document concludes that more research is needed to better understand and treat primary cicatricial alopecias, and suggests a possible reclassification based on molecular pathways.